Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGüner, Ahmet
dc.contributor.authorKalçık, Macit
dc.contributor.authorÇelik, Mehmet
dc.contributor.authorUzun, Fatih
dc.contributor.authorÇizgici, Ahmet Yaşar
dc.contributor.authorZencirkıran Ağuş, Hicaz
dc.contributor.authorKalkan, Mehmet Emin
dc.date.accessioned2021-11-01T15:05:09Z
dc.date.available2021-11-01T15:05:09Z
dc.date.issued2020
dc.identifier.citationGüner, A., Kalçık, M., Çelik, M., Uzun, F., Çizgici, A. Y., Ağuş, H. Z., ... & Kalkan, M. E. (2020). Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry). Journal of Electrocardiology, 63, 83-90.en_US
dc.identifier.issn0022-0736
dc.identifier.issn1532-8430
dc.identifier.urihttps://doi.org/10.1016/j.jelectrocard.2020.10.009
dc.identifier.urihttps://hdl.handle.net/11491/7144
dc.description.abstractBackground: Hypertrophic cardiomyopathy (HCM) is significantly associated with high risk of fatal ventricular arrhythmias (VAs). Increased frontal QRST angle (fQRSTa), Tpe interval, and Tp-e/QTc ratio are described as ventricular repolarization parameters which are related to arrhythmias. In this study, we aimed to investigate the predictive value of these repolarization parameters for fatal VAs in patients with HCM. Methods: A total of 127 HCM patients (mean age: 47.9 +/- 12.6 years; male:79) were enrolled in this retrospective study. All patients underwent transthoracic echocardiography. Moreover, the last electrocardiograms within 3 months prior to the fatal VA documentation were assessed. The primary outcome was the occurrence of fatal VAs including sustained ventricular tachycardia and ventricular fibrillation which were documented from implantable cardioverter defibrillator records. Results: There were documented fatal VAs in 37 (29.1%) patients during a mean follow-up time of 70.1 +/- 22.6 months. The prevalence of fatal VAs was significantly higher in patients with fQRSTa >= 140 degrees (67.4 vs. 7.4%; p < 0.001) and in patients with Tp-e/QTc ratio >= 0.19 (61.5 vs. 6.7%; p < 0.001) as compared to others. High Tp-e/QTc ratio (hazard ratio: 1.564; 95% confidence interval: 1.086-4.796; p = 0.032) and high fQRSTa (hazard ratio: 1.864; 95% confidence interval: 1.106-8.745; p = 0.002) were found to be independent predictors of fatal VAs in HCM patients. Conclusions: Wider fQRSTa, prolonged Tp-e interval, and increased Tp-e/QTc ratio may be associated with fatal VAs in HCM patients. In addition to traditional risk factors, these simple ECG parameters may provide valuable information during evaluation of sudden cardiac death risk in HCM patients. (C) 2020 Elsevier Inc. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherChurchill Livingstone Inc Medical Publishersen_US
dc.relation.ispartofJournal Of Electrocardiologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHypertrophic Cardiomyopathyen_US
dc.subjectFrontal QRS-T Angleen_US
dc.subjectSudden Cardiac Deathen_US
dc.subjectTp-e/QTc Ratioen_US
dc.titleImpaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry)en_US
dc.typearticleen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume63en_US
dc.identifier.startpage83en_US
dc.identifier.endpage90en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Guner, Ahmet; Uzun, Fatih; Cizgici, Ahmet Yasar; Agus, Hicaz Zencirkiran; Aslan, Serkan; Guner, Ezgi Gultekin; Ulutas, Ahmet Emir] Mehmet Akif Ersoy Thorac & Cardiovasc Surg Traini, Dept Cardiol, Turgut Ozal Bulvari 11, TR-34303 Istanbul, Turkey; [Kalcik, Macit] Hitit Univ, Fac Med, Dept Cardiol, Corum, Turkey; [Celik, Mehmet; Bayam, Emrah; Kalkan, Mehmet Emin] Kosuyolu Kartal Heart Training & Res Hosp, Dept Cardiol, Istanbul, Turkeyen_US
dc.contributor.institutionauthorKalçık, Macit
dc.identifier.doi10.1016/j.jelectrocard.2020.10.009
dc.description.wospublicationidWOS:000600694400019en_US
dc.description.scopuspublicationid2-s2.0-85094805794en_US
dc.description.pubmedpublicationidPubMed: 33142186en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster